SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-233152
Filing Date
2018-07-31
Accepted
2018-07-31 16:09:50
Documents
17
Effectiveness Date
2018-07-31

Document Format Files

Seq Description Document Type Size
1 S-8 d347801ds8.htm S-8 73716
2 EX-4.1 d347801dex41.htm EX-4.1 595594
3 EX-4.2 d347801dex42.htm EX-4.2 444133
4 EX-5.1 d347801dex51.htm EX-5.1 49331
5 EX-23.1 d347801dex231.htm EX-23.1 1616
6 EX-23.2 d347801dex232.htm EX-23.2 1725
7 EX-99.1 d347801dex991.htm EX-99.1 131022
8 EX-99.2 d347801dex992.htm EX-99.2 34993
9 EX-99.3 d347801dex993.htm EX-99.3 8748
10 EX-99.4 d347801dex994.htm EX-99.4 341442
11 EX-99.5 d347801dex995.htm EX-99.5 4367
12 GRAPHIC g347801dsp10.jpg GRAPHIC 3478
13 GRAPHIC g347801dsp10a.jpg GRAPHIC 3160
14 GRAPHIC g347801dsp10b.jpg GRAPHIC 2866
15 GRAPHIC g347801g0518075757750.jpg GRAPHIC 2524
16 GRAPHIC g347801g85e65.jpg GRAPHIC 3267
17 GRAPHIC g347801snap1.jpg GRAPHIC 9898
  Complete submission text file 0001193125-18-233152.txt   1723433
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-226457 | Film No.: 18981207
SIC: 2836 Biological Products, (No Diagnostic Substances)